View All Documents & Correspondence
Targeted Drug Conjugate, Medicine Including The Same, And Compound
Abstract: Provided is a compound or a salt thereof, said compound including: two or more structural parts M that are selected from a biologically active substance part and a radioisotope-including part; and a structure that is represented by general formula (I). Also provided are a targeted drug conjugate and a medicine including the same. However, said compound and salt do not have a fluorescent substance part, and have at least one type of group selected from a specific group Pi of hydrophilic groups. In the formula, X1 to X3 each represent –O–, –S–, >NR1, or >CR2R3, R1 to R3 and R11 each represent a hydrogen atom or a substituent, n is an integer greater than or equal to 2, and * is a bonding site.
Notices, Deadlines & Correspondence
Patent Information
Applicants
FUJIFILM CORPORATION
Inventors
1. TAMURA, Takashi
2. WATANABE, Kousuke
3. TANAKA, Hiroaki
Specification
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 202617032941-TRANSLATION OF PRIORITY DOCUMENTS ETC. [18-03-2026(online)].pdf | 2026-03-18 |
| 2 | 202617032941-STATEMENT OF UNDERTAKING (FORM 3) [18-03-2026(online)].pdf | 2026-03-18 |
| 3 | 202617032941-PROOF OF RIGHT [18-03-2026(online)].pdf | 2026-03-18 |
| 4 | 202617032941-POWER OF AUTHORITY [18-03-2026(online)].pdf | 2026-03-18 |
| 5 | 202617032941-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [18-03-2026(online)].pdf | 2026-03-18 |
| 6 | 202617032941-FORM 18 [18-03-2026(online)].pdf | 2026-03-18 |
| 7 | 202617032941-FORM 1 [18-03-2026(online)].pdf | 2026-03-18 |
| 8 | 202617032941-DECLARATION OF INVENTORSHIP (FORM 5) [18-03-2026(online)].pdf | 2026-03-18 |
| 9 | 202617032941-COMPLETE SPECIFICATION [18-03-2026(online)].pdf | 2026-03-18 |
| 10 | 202617032941-WIPO_PCT_DOC.pdf | 2026-04-09 |
| 11 | 202617032941-PATENT_APPLICATION_PUBLICATION.pdf | 2026-05-02 |